Skip to main content
. 2024 Aug 8;14(3):1093–1108. doi: 10.3390/jox14030062

Table 1.

Baseline characteristics of the participating women (n = 51).

Demographic Characteristics
Age (years), median [IQR] 39.00 [38.00, 41.00]
Body mass index (kg/m2), median [IQR] 22.97 [20.63, 25.12]
Race/ethnic group, n (%)
  • -

    Hispanic-White

48 (94.1%)
  • -

    Afro-American

1 (2.0%)
  • -

    Hispanic

1 (2.0%)
  • -

    Other

1 (2.0%)
Education, n (%)
  • -

    Elementary school

3 (6.5%)
  • -

    High school

5 (10.9%)
  • -

    Trade school

5 (10.9%)
  • -

    University

33 (71.7%)
Smoking, n (%)
  • -

    Never smoked

23 (50.0%)
  • -

    Ex-smoker

13 (28.3%)
  • -

    Active smoker

9 (19.6%)
  • -

    Passive smoker

1 (2.2%)
Reproductive Characteristics
Total FSH + hMG dose during COS (IU), median [IQR] 3300.00 [2437.50, 3925.00]
Trigger day E2 (pg/mL), median [IQR] 2083.00 [1622.50, 4045.50]
Number of retrieved oocytes, median [IQR] 12.00 [7.00, 16.00]
Maturation rate, % mean ± SD 80 ± 17%
Fertilization rate, % mean ± SD 75 ± 25%
Blastulation rate, % mean ± SD 54 ± 28%
Euploidy rate, % mean ± SD 42 ± 34%
Embryo transfer rate, n (%) 36 (70.6%)
Implantation (positive hCG) rate, n (%) 23 (63.9%)
Clinical pregnancy rate, n (%) 19 (52.8%)
Live birth rate, n (%) 17 (47.2%)
Reproductive goal rate, n (%) 17 (33.3%)

Note: The reproductive goal rate refers to the achievement of a live birth within a given cycle. COS, controlled ovarian stimulation; E2, estradiol; FSH, follicle-stimulating hormone; hCG, human chorionic gonadotropin; hMG, human menopausal gonadotropin; IQR, interquartile range; n, number; SD, standard deviation.